Litcius/Paper detail

Efficacy and mechanisms of 4-week MBSR on psychological distress in lung cancer patients: A single-center, single-blind, longitudinal, randomized controlled trial

Xu Tian, Zhongli Liao, Li-Juan Yi, Ling Tang, Guihua Chen, María Herrera

2022Asia-Pacific Journal of Oncology Nursing20 citationsDOIOpen Access PDF

Abstract

Objective: This study aimed to evaluate the efficacy of a 4-week mindfulness-based stress reduction (MBSR) program on psychological distress in patients with lung cancer and elucidate its mechanisms. Methods: This single-center, single-blinded, longitudinal, randomized controlled trial was conducted on 175 patients with lung cancer randomly allocated to a 4-week MBSR or a waiting-list group. The efficacy and mechanisms of the 4-week MBSR program were evaluated by outcome measures at preintervention (T0), the immediate postintervention (T1), 1 month (T2), and 3 months (T3). We analyzed the collected data using the per-protocol set principle, independent sample t-test, repeated measure analysis of variance, and structural equation modeling. Results: ​= ​0.005). Conclusions: This study shows the benefits of the MBSR program for psychological distress, social support, mindfulness, and perceived stigma in patients with lung cancer. Also, it elucidates the mechanisms by which the MBSR program alleviates psychological distress by improving social support, enhancing mindfulness, and decreasing perceived stigma. The findings provide insights into applying the MBSR program to reduce psychological distress among patients with lung cancer.

Topics & Concepts

MindfulnessMindfulness-based stress reductionDistressSocial supportRandomized controlled trialClinical psychologyMedicineRepeated measures designLung cancerPsychologyInternal medicinePsychotherapistMathematicsStatisticsCancer survivorship and careMindfulness and Compassion InterventionsCardiac Health and Mental Health
Efficacy and mechanisms of 4-week MBSR on psychological distress in lung cancer patients: A single-center, single-blind, longitudinal, randomized controlled trial | Litcius